マンモグラフィシステム市場（製品種類別、技術別、エンドユーザー別、地域別）：将来予測（2026～2032年）

マンモグラフィシステム市場の評価（2026～2032年）

乳がん罹患率の上昇により、早期発見と検診の必要性に対する認識が高まり、マンモグラフィシステム市場の成長を牽引しています。定期的なマンモグラフィ検査を支援する政府の取り組みや医療政策が、新興国における医療インフラの拡大とともに市場の成長を加速させています。さらに、乳がん早期発見のメリットに対する一般市民の認識が高まり、予防的な医療習慣の導入が進んだことも、市場成長に大きく寄与しています。マンモグラフィシステム市場は、2024年に24億8,000万米ドルの収益を突破し、2032年には45億6,000万米ドルに達すると推計されます。

同市場は、乳がんの早期発見と患者の転帰を改善することを目的とした技術の進歩により、大幅な成長を遂げています。デジタルマンモグラフィは、従来のフィルムベースのシステムに取って代わり、優れた画質と被曝線量の低減を実現しています。デジタル乳房トモシンセシスとしても知られる3Dマンモグラフィの導入により、多層撮影が可能になり、高濃度乳腺組織の異常検出が強化されました。同市場は、2026年から2032年にかけてCAGR 7.90％で成長すると予測されます。

マンモグラフィシステム市場の定義/概要

マンモグラフィシステムは、主に乳がんの検出を目的として、乳房組織の詳細な画像を撮影するために使用される診断ツールです。このシステムは、低線量X線を使用して乳房の画像を生成し、医療専門家が組織の異常や変化を特定できるようにします。このシステムは、乳がんの早期発見により治療成績が大幅に向上する検診と診断の両方に不可欠です。

この技術は、病院、診断センター、専門クリニックで広く採用されています。検査では、乳房を2枚のプレートで挟んで圧迫し、X線を組織に照射します。生成された画像は腫瘍やその他の異常の兆候がないか分析されます。この分野の進歩により、デジタル・マンモグラフィや3Dマンモグラフィが導入され、画質や精度が向上し、特に乳腺組織が密集している場合に有効です。

マンモグラフィシステムの将来は、人工知能（AI）の統合や画像処理技術の強化など、さらなる技術的進歩に焦点が当てられると予想されます。AIアルゴリズムは、放射線科医がより高い精度で早期乳がんを検出できるよう開発されています。

乳がん検出におけるマンモグラフィシステムの需要増に、技術の進歩と政府の取り組みはどのように寄与しているか？

デジタルマンモグラフィや3Dマンモグラフィの開発などの技術進歩により、乳がん検出の精度と効率が向上しました。デジタルマンモグラフィは、従来のフィルムベースのシステムと比較して、より高画質で放射線被曝量が少ないです。3Dマンモグラフィ（デジタル乳房トモシンセシス）の導入により、多層撮影が可能になり、高濃度乳腺組織の異常検出が向上しました。これらの技術革新により、マンモグラフィシステムは医療提供者と患者の双方にとって、より効果的で魅力的なものとなっています。

定期検診を推進し、早期がん発見のためのマンモグラフィの使用を支援するガイドラインを提供することにより、政府のイニシアチブは重要な役割を果たしています。公衆衛生プログラムには、特に十分なサービスを受けていない地域で、マンモグラフィを利用しやすくするための資金や資源が含まれていることが多いです。このような政策は定期的な検診を奨励し、早期発見率を高め、高度なマンモグラフィ技術の需要を促進します。

新しいマンモグラフィ技術を導入する際、医療提供者はどのような障害に直面し、これらの課題は患者の転帰やシステムパフォーマンスにどのように影響するのか？

医療提供者は、新しいマンモグラフィ技術を導入する際にいくつかの障害に直面します。3Dマンモグラフィのような先進的なマンモグラフィシステムは、購入、設置、メンテナンスに多額の資金を必要とするため、高額な費用が大きな課題となっています。このような高コストにより、特に資金不足の医療環境や地方の医療環境では、これらの技術の利用が制限される可能性があります。

トレーニングや専門知識も重要な問題です。新しい技術では、正確な使用法と結果の解釈を確実にするために、放射線科医や技師に追加のトレーニングが必要になることが多いです。トレーニングが不十分だと、性能が最適でなくなり、診断精度に影響を及ぼす可能性があります。既存のシステムとの統合も課題です。新しいマンモグラフィシステムは、電子カルテ（EHR）や画像診断システムなど、既存の医療ITインフラとの互換性が必要です。統合の問題は、効果的な患者ケアに不可欠なシームレスなワークフローとデータ管理の妨げとなる可能性があります。

患者の快適さとアクセスは、先端技術の導入によって影響を受ける可能性があります。新しいシステムはより良い画像診断を提供する一方で、患者の快適性やアクセス性に影響を与えるような、より長い処置や追加の手順を必要とすることもあります。

目次

第1章 世界のマンモグラフィシステム市場：イントロダクション

• 市場概要
• 分析範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの分析手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界のマンモグラフィシステム市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 世界のマンモグラフィシステム市場：技術別

• 概要
• スクリーンフィルムマンモグラフィ
• デジタルマンモグラフィ
• 3Dマンモグラフィ

第6章 世界のマンモグラフィシステム市場：製品種類別

• 概要
• フルフィールドデジタルマンモグラフィ
• アナログマンモグラフィシステム
• 乳房トモシンセシスシステム

第7章 世界のマンモグラフィシステム市場：エンドユーザー別

• 概要
• 病院
• 診断センター
• 専門クリニック

第8章 世界のマンモグラフィシステム市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• その他の地域 (ROW)
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界のマンモグラフィシステム市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Philips N.V
• General Electric Company
• Analogic Corporation
• Carestream Health Inc.
• Fujifilm Holdings Corporation
• Delphinus Medical Technologies
• Hologic Inc
• Planmed Oy
• IMS Giotto S.P.A
• Konica Minolta Inc

第11章 企業プロファイル：付録

• 関連分析

Mammography Systems Market Valuation - 2026-2032

The rising prevalence of breast cancer is increasing awareness and the need for early detection and screening, driving growth in the mammography systems market. Government initiatives and healthcare policies supporting routine mammograms, together with the expansion of healthcare infrastructure in emerging nations, have accelerated market growth. Furthermore, greater public awareness of the benefits of early breast cancer detection, as well as increased adoption of preventative healthcare practices, all contribute considerably to market growth. The mammography systems market is estimated to surpass a revenue of USD 2.48 Billion in 2024 and reach USD 4.56 Billion by 2032.

The market has experienced substantial growth, driven by technological advancements aimed at improving early breast cancer detection and patient outcomes. Digital mammography has largely replaced traditional film-based systems, offering superior image quality and reduced radiation exposure. The introduction of 3D mammography, also known as digital breast tomosynthesis, allows for multi-layered imaging, enhancing the detection of abnormalities in dense breast tissue. The market is anticipated to grow at a CAGR of 7.90% from 2026 to 2032.

Mammography Systems Market: Definition/ Overview

Mammography systems are diagnostic tools used to capture detailed images of breast tissue, primarily for the detection of breast cancer. These systems use low-dose X-rays to produce images of the breast, enabling healthcare professionals to identify abnormalities or changes in the tissue. The systems are essential in both screening and diagnostic procedures, where early detection of breast cancer significantly improves treatment outcomes.

The technology is widely employed in hospitals, diagnostic centers, and specialized clinics. During the procedure, the breast is compressed between two plates, and X-rays are passed through the tissue. The images produced are analyzed for signs of tumors or other irregularities. Advances in the field have introduced digital and 3D mammography, which offer improved image quality and accuracy, especially in dense breast tissue.

The future of mammography systems is anticipated to focus on further technological advancements, such as artificial intelligence (AI) integration and enhanced imaging techniques. AI algorithms are being developed to assist radiologists in detecting early-stage breast cancer with greater precision.

How Do Technological Advancements and Government Initiatives Contribute to the Increasing Demand for Mammography Systems in Breast Cancer Detection?

Technological advancements such as the development of digital mammography and 3D mammography have improved the accuracy and efficiency of breast cancer detection. Digital mammography offers higher image quality and lower radiation exposure compared to traditional film-based systems. The introduction of 3D mammography, or digital breast tomosynthesis, enables multi-layered imaging, which enhances the detection of abnormalities in dense breast tissue. These innovations have made mammography systems more effective and appealing for both healthcare providers and patients.

Government initiatives play a crucial role by promoting routine screening and providing guidelines that support the use of mammography for early cancer detection. Public health programs often include funding and resources to make mammography accessible, especially in underserved areas. Such policies encourage regular screenings, which increase early detection rates and drive demand for advanced mammography technologies.

What Obstacles do Healthcare Providers Encounter when Implementing New Mammography Technologies, and how do these Challenges Affect Patient Outcomes and System Performance?

Healthcare providers face several obstacles when implementing new mammography technologies, which can impact patient outcomes and system performance. High costs are a significant challenge, as advanced mammography systems, such as 3D mammography, require substantial financial investment for purchase, installation, and maintenance. This high cost can limit the availability of these technologies, particularly in underfunded or rural healthcare settings.

Training and expertise are also crucial issues. New technologies often necessitate additional training for radiologists and technicians to ensure accurate usage and interpretation of results. Insufficient training can lead to suboptimal performance and potentially affect diagnostic accuracy. Integration with existing systems poses another challenge. New mammography systems need to be compatible with existing healthcare IT infrastructure, including electronic health records (EHRs) and imaging systems. Integration issues can hinder the seamless workflow and data management essential for effective patient care.

Patient comfort and access can be affected by the introduction of advanced technologies. While new systems offer better imaging, they may also require longer procedures or additional steps that impact patient comfort and accessibility.

Category-Wise Acumens

What are the Key Advantages of Full-Field Digital Mammography over Analog Mammography Systems in Breast Cancer Detection?

Full-field mammography segment significantly dominates the mammography systems market. Full-field digital mammography (FFDM) provides significant advantages over Analog Mammography Systems in breast cancer detection. FFDM offers superior image quality with higher resolution and greater detail, enabling better visualization of small or subtle abnormalities. This enhanced clarity improves diagnostic accuracy. FFDM typically requires lower radiation doses, reducing patient exposure while still maintaining effective screening results. The faster image acquisition and processing times associated with digital systems enhance efficiency, reducing the time patients spend in imaging and allowing for quicker diagnosis.

The digital images can be easily manipulated, such as adjusting contrast and brightness, which assists radiologists in detecting and analyzing potential issues more effectively. These benefits collectively make FFDM a more advanced and effective tool for breast cancer detection compared to traditional analog mammography systems.

What Factors Influence the Choice of Mammography Systems in Diagnostic Centers Compared to Hospitals, and how do these Factors Affect their Implementation and Patient Outcomes?

The choice of mammography systems in diagnostic centers compared to hospitals is influenced by various factors affecting their implementation and patient outcomes. Cost and budget constraints often drive diagnostic centers to select cost-effective systems that provide a balance between quality and affordability. In contrast, hospitals with larger budgets might invest in the latest advanced technologies, such as 3D mammography systems, to offer comprehensive services. The volume of patients plays a role; hospitals, managing higher patient loads, may require high-capacity systems for efficiency, while diagnostic centers, which focus on specialized screenings, might choose high-resolution systems for detailed analysis.

Space and infrastructure are also considerations, with diagnostic centers opting for more compact or versatile systems due to limited space, whereas hospitals can accommodate larger systems and integrate them into extensive imaging departments. Finally, diagnostic centers may prioritize state-of-the-art technologies due to their specialization in mammography, while hospitals integrate mammography with a broader range of diagnostic modalities.

What Factors Contribute to North America's Leadership In the Mammography Systems Market, and how do these Factors Influence the Adoption of Advanced Technologies In the Region?

North America significantly dominates the mammography systems and it is expected to maintain throughout the forecast period driven by the United States, the largest economy in North America, which generates the majority of the market's revenue. High healthcare spending in countries like the United States and Canada supports the acquisition of advanced mammography systems and funds comprehensive screening programs. The region's well-established healthcare infrastructure, including state-of-the-art medical facilities, is well-equipped to integrate and utilize advanced technologies such as digital and 3D mammography.

Government initiatives also play a crucial role in robust public health campaigns and policies promoting early breast cancer detection driving demand for advanced systems. North America is a leader in technological innovation, being at the forefront of developing and implementing cutting-edge mammography technologies that enhance diagnostic accuracy and patient outcomes. These factors together ensure that North America remains a global leader in the mammography systems market, influencing both technology adoption and market expansion.

How is the Adoption of Mammography Systems Evolving in the Asia-Pacific Region?

The Asia-Pacific region is anticipated to experience the fastest growth in the mammography systems market during the forecast period driven by rapid economic growth in countries is leading to increased healthcare investment, which supports the procurement of advanced medical technologies, including mammography systems. The expansion of healthcare infrastructure and the development of new healthcare facilities are making sophisticated diagnostic tools more accessible. Government initiatives aimed at improving cancer screening and early detection, particularly in emerging economies, are also driving market growth. Public health campaigns and increased awareness about breast cancer are contributing to higher demand for mammography services.

The partnerships between international companies and local healthcare providers are facilitating the introduction and expansion of advanced mammography technologies in the region. These collaborative efforts help address disparities in access to quality screening services and support the implementation of digital and 3D mammography systems. The Asia-Pacific region is experiencing a notable increase in the adoption of mammography systems, driven by economic development, healthcare expansion, and a growing emphasis on early cancer detection.

Competitive Landscape

The competitive landscape of the Mammography Systems Market is dynamic and constantly evolving. New players are entering the market, and existing players are investing in research and development to maintain their competitive edge. The market is characterized by intense competition, rapid technological advancements, and a growing demand for innovative and efficient solutions.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the mammography systems market include:

• Philips N.V.
• General Electric Company
• Analogic Corporation
• Carestream Health, Inc.
• Planmed Oy
• Delphinus Medical Technologies
• Fujifilm Holdings Corporation
• Hologic, Inc.
• IMS Giotto S.P.A
• Konica Minolta Inc.

Latest Developments

• In April 2024, Hologic Inc. has announced its acquisition of Endomag, a breast care company, for $310 million. This acquisition aims to expand Hologic's breast surgery portfolio with Endomag's technologies, including the Magseed marker for magnetic tissue localization, Magtrace injectable for lymphatic tracing in breast cancer staging, and the Sentimag platform. These additions will enhance options for surgeons and radiologists, catering to the specific needs of patients undergoing critical breast cancer procedures.
• In December 2024, Lunit, a medical AI company, has agreed to acquire Volpara Health Technologies, based in New Zealand and known for its AI-powered software for early detection of breast cancer.

Mammography Systems Market, By Category

• Product Type:
• Full-Field Digital Mammography
• Analog Mammography Systems
• Breast Tomosynthesis Systems
• Technology:
• Screen-Film Mammography
• Digital Mammography

3D Mammography

• End-User:
• Hospitals
• Diagnostic Centers
• Specialty Clinics
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MAMMOGRAPHY SYSTEMS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL MAMMOGRAPHY SYSTEMS OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY

• 5.1 Overview
• 5.2 Screen-Film Mammography
• 5.3 Digital Mammography
• 5.4 3D Mammography

6 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY PRODUCT TYPE

• 6.1 Overview
• 6.2 Full-Field Digital Mammography
• 6.3 Analog Mammography Systems
• 6.4 Breast Tomosynthesis Systems

7 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY END USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Diagnostic Centers
• 7.4 Specialty Clinics

8 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL MAMMOGRAPHY SYSTEMS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Philips N.V
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 General Electric Company
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Analogic Corporation
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Carestream Health Inc.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Fujifilm Holdings Corporation
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Delphinus Medical Technologies
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Hologic Inc
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Planmed Oy
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 IMS Giotto S.P.A
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Konica Minolta Inc
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Research